Allstocks.com's Bulletin Board Post New Topic  New Poll  Post A Reply
my profile login | register | search | faq | forum home

  next oldest topic   next newest topic
» Allstocks.com's Bulletin Board » Pink Sheet Stocks » SHMN NEWS:

 - UBBFriend: Email this page to someone!    
Author Topic: SHMN NEWS:
scooz
Member


Rate Member
Icon 1 posted      Profile for scooz     Send New Private Message       Edit/Delete Post   Reply With Quote 
SHMN NEWS:Aug 26, 2010 08:23 ET
SOHM Reports Consecutive Record Quarters With 1,000 Percent Year-Over-Year Revenue Increase for the Second Quarter 2010
Consumer Adoption of SOHM's Private Label Generic Pharmaceutical Products Driving Unprecedented Corporate Revenue Growth
BUENA PARK, CA--(Marketwire - August 26, 2010) - SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories, today announced that it has posted a 1,000 percent year-over-year increase in revenue for the second quarter ending June 30, 2010. Due to successive record quarters and the company's unprecedented corporate revenue growth the Company expects continued consumer adoption of its private label generic pharmaceutical products. Revenues for the three months ended June 30, 2010 increased over 1,000% to $339,545 compared to $33,599 in the second quarter of 2009. Revenue growth was fueled by expansion of current and new clients and from pilot distribution projects to full production deployments.
Shailesh Shah, Vice President for Corporate Strategy at SOHM, Inc., stated, "Our ability to generate record revenue growth and accelerated consumer adoption rates for our generic pharmaceutical products is a direct reflection of our sales and marketing team's dedication. We continue to demonstrate our ability to penetrate and lead in our chosen emerging markets. Most significantly, SOHM has grown and matured its generic drug manufacturing operations allowing for the scalability of resources and product production necessary to support a growing worldwide customer base."
About SOHM, Inc.
SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters are located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia. www.sohm.com
Safe Harbor Statement
This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
For more information, please contact:
SOHM, Inc.
Investor Relations
(714) 522-6700

Posts: 598 | Registered: Mar 2005  |  IP: Logged | Report this post to a Moderator
luckylindy
Member


Member Rated:
4
Icon 1 posted      Profile for luckylindy     Send New Private Message       Edit/Delete Post   Reply With Quote 
SHMN looks like it has the factors to be an undiscovered gem based upon both fundamental and technical standpoints.

They have announced an expansion of their manufacturing facility as well as their pharmaceutical line to 280 products....plus have upgraded to fully-reporting status with the intent to transition to OTCBB Quotation System, per their May 5th announcement.

Posts: 809 | From: florida | Registered: Dec 2008  |  IP: Logged | Report this post to a Moderator
wolyton
Member


Rate Member
Icon 1 posted      Profile for wolyton     Send New Private Message       Edit/Delete Post   Reply With Quote 
UENA PARK, CA, Aug 26, 2010 (MARKETWIRE via COMTEX) -- SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories, today announced that it has posted a 1,000 percent year-over-year increase in revenue for the second quarter ending June 30, 2010. Due to successive record quarters and the company's unprecedented corporate revenue growth the Company expects continued consumer adoption of its private label generic pharmaceutical products. Revenues for the three months ended June 30, 2010 increased over 1,000% to $339,545 compared to $33,599 in the second quarter of 2009. Revenue growth was fueled by expansion of current and new clients and from pilot distribution projects to full production deployments.
Shailesh Shah, Vice President for Corporate Strategy at SOHM, Inc., stated, "Our ability to generate record revenue growth and accelerated consumer adoption rates for our generic pharmaceutical products is a direct reflection of our sales and marketing team's dedication. We continue to demonstrate our ability to penetrate and lead in our chosen emerging markets. Most significantly, SOHM has grown and matured its generic drug manufacturing operations allowing for the scalability of resources and product production necessary to support a growing worldwide customer base."

About SOHM, Inc. SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters are located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia. www.sohm.com

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

--------------------
what i post is my opinion

Posts: 304 | Registered: Sep 2009  |  IP: Logged | Report this post to a Moderator
wolyton
Member


Rate Member
Icon 1 posted      Profile for wolyton     Send New Private Message       Edit/Delete Post   Reply With Quote 
the recent expansions in the company has made the volume skyrocket

--------------------
what i post is my opinion

Posts: 304 | Registered: Sep 2009  |  IP: Logged | Report this post to a Moderator
arizonagold
Member


Member Rated:
4
Icon 1 posted      Profile for arizonagold     Send New Private Message       Edit/Delete Post   Reply With Quote 
SHMN -

I know it's late, but this company did great today. Check it out for early morning. IMO

Posts: 143 | Registered: Apr 2010  |  IP: Logged | Report this post to a Moderator
luckylindy
Member


Member Rated:
4
Icon 1 posted      Profile for luckylindy     Send New Private Message       Edit/Delete Post   Reply With Quote 
SOHM Signs Exclusive Agreement for Distribution of Generic Pharmaceuticals in Sri Lanka
SOHM (OTC) (USOTC:SHMN)
Intraday Stock Chart
Today : Friday 27 August 2010

SOHM, Inc. (PINKSHEETS: SHMN) announced today that it has further broadened its international sales channels in Southeast Asia by signing an exclusive distribution agreement for the marketing and distribution of SOHM's private label generic pharmaceutical products in Sri Lanka. The Company is positioned to capitalize and increase market share in the world's fastest-growing pharmaceutical market: Southeast Asia.

The Company's direct manufacturing of generic pharmaceuticals allows pricing advantages and distribution of quality drugs to consumers remaining underserved or with limited access to medicine in Southeast Asia. Health issues not being addressed in this region such as contagious diseases and life style disorders such as cardiovascular, diabetes, musculoskeletal disorders and cancer offer an exceptional opportunity to expand SOHM's market share and serve the populations of these countries.

Southeast Asia is the fourth-largest pharmaceutical market in the world, behind the United States, Japan, and Europe. Southeast Asia is also the world's fastest-growing pharmaceutical market. Factors driving this market expansion include economic growth, a broadening middle class, growing and aging population, increasing economic liberalization, and an expanded government and private-sector role in improving health care. According to BMI's drug expenditure forecast model, pharmaceutical sales in Sri Lanka are expected to increase from US$339 million in 2009 to US$388 million in 2010 with a 12.6% growth rate. Sri Lanka is ranked as the most liberalized economy in South Asia and is positioned as the Gateway to Asia, with its open economy and superior logistics for serving as a regional trade hub.

"This agreement is another significant milestone in our goal to increase international distribution of SOHM's private label pharmaceutical products and increases our market advantage in Southeast Asia," stated Shailesh Shah, Vice President for Corporate Strategy at SOHM, Inc. "We believe this market has tremendous potential for our generic pharmaceutical products and we are confident that our sales team can maximize our market penetration making SOHM a leading generic drug brand in this region."

About SOHM, Inc.

SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters are located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia. www.sohm.com

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

For more information, please contact:

SOHM, Inc.

Investor Relations

(714) 522-6700

Email Contact

Posts: 809 | From: florida | Registered: Dec 2008  |  IP: Logged | Report this post to a Moderator
wolyton
Member


Rate Member
Icon 1 posted      Profile for wolyton     Send New Private Message       Edit/Delete Post   Reply With Quote 
Another green day the stock is going for a big run!

--------------------
what i post is my opinion

Posts: 304 | Registered: Sep 2009  |  IP: Logged | Report this post to a Moderator
wolyton
Member


Rate Member
Icon 1 posted      Profile for wolyton     Send New Private Message       Edit/Delete Post   Reply With Quote 
Stocksource.us brings you all the Stocks in the News: SOHM Inc. (PINKSHEETS: SHMN), South Shore Resources Inc. (Pink Sheets: SSHO), B2 Digital Inc. (Pink Sheets:BTDG), My Social Income Inc. (Pink Sheets:MSOA)
Receive all the news and alerts first. Sign up for the news letter :http://www.stocksource.us

For stock picks and investment community interaction please follow us on http://www.facebook.com/stockp and www.twitter.com/penny_stock

SOHM Inc. (PINKSHEETS: SHMN)

BUENA PARK, CA -- 08/27/10 -- SOHM Inc. (PINKSHEETS: SHMN) announced today that it has further broadened its international sales channels in Southeast Asia by signing an exclusive distribution agreement for the marketing and distribution of SOHM's private label generic pharmaceutical products in Sri Lanka. The Company is positioned to capitalize and increase market share in the world's fastest-growing pharmaceutical market: Southeast Asia.

The Company's direct manufacturing of generic pharmaceuticals allows pricing advantages and distribution of quality drugs to consumers remaining underserved or with limited access to medicine in Southeast Asia. Health issues not being addressed in this region such as contagious diseases and life style disorders such as cardiovascular, diabetes, musculoskeletal disorders and cancer offer an exceptional opportunity to expand SOHM's market share and serve the populations of these countries.

Southeast Asia is the fourth-largest pharmaceutical market in the world, behind the United States, Japan, and Europe. Southeast Asia is also the world's fastest-growing pharmaceutical market. Factors driving this market expansion include economic growth, a broadening middle class, growing and aging population, increasing economic liberalization, and an expanded government and private-sector role in improving health care. According to BMI's drug expenditure forecast model, pharmaceutical sales in Sri Lanka are expected to increase from US$339 million in 2009 to US$388 million in 2010 with a 12.6% growth rate. Sri Lanka is ranked as the most liberalized economy in South Asia and is positioned as the Gateway to Asia, with its open economy and superior logistics for serving as a regional trade hub.

"This agreement is another significant milestone in our goal to increase international distribution of SOHM's private label pharmaceutical products and increases our market advantage in Southeast Asia," stated Shailesh Shah, Vice President for Corporate Strategy at SOHM, Inc. "We believe this market has tremendous potential for our generic pharmaceutical products and we are confident that our sales team can maximize our market penetration making SOHM a leading generic drug brand in this region."

--------------------
what i post is my opinion

Posts: 304 | Registered: Sep 2009  |  IP: Logged | Report this post to a Moderator
   

Quick Reply
Message:

HTML is not enabled.
UBB Code™ is enabled.
UBB Code™ Images not permitted.
Instant Graemlins
   


Post New Topic  New Poll  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | Allstocks.com Message Board Home

© 1997 - 2013 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share